The market grew from USD 1.32 billion in 2023 to USD 1.52 billion in 2024, and is projected to reach USD 3.89 billion by 2030, growing at a 16.6 % CAGR, driven by rising cancer prevalence, R&D investments, and expanded use in BCC and leukemia https://www.datamintelligence.com/research-report/hedgehog-pathway-inhibitors-market?dr